Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
FGF
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Votrient
(pazopanib) / Novartis, BeiGene
Focus V
(anlotinib) / Advenchen, Sino Biopharm
Stivarga
(regorafenib) / Bayer
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Sulanda
(surufatinib) / Hutchmed
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
Kinaction
(masitinib) / AB Science
Lytgobi
(futibatinib) / Otsuka
dovitinib
(TKI258) / Novartis, Oncoheroes
Retevmo
(selpercatinib) / Eli Lilly
Balversa
(erdafitinib) / J&J
Iclusig
(ponatinib) / Takeda, Otsuka
nintedanib
/ Generic mfg.
CPL304110
/ Celon Pharma
ENMD-2076
/ CASI
Kepivance
(palifermin) / SOBI, Amgen
Pemazyre
(pemigatinib) / Incyte
Truseltiq
(infigratinib) / BridgeBio, Pfizer, Xediton Pharma
brivanib alaninate
(BMS-582664) / ZAI Lab
rogaratinib
(BAY 1163877) / Bayer
thrombospondin-1 mimetic
(ABT-510) / AbbVie
tinengotinib
(TT-00420) / TransThera Biosci
